Our patient-inspired R&D approach is grounded in a thoughtful focus on the real-world challenges that patients with central nervous system (CNS) disorders face on a daily basis. Through this lens, we seek to develop new medications that offer significant medical benefits, including improved efficacy, safety and ease-of-use for both patients and caregivers—all with the ultimate goal of reducing suffering and improving treatment outcomes for millions.
Uncovering unmet needs
By identifying distinct areas of unmet patient needs within the major CNS diseases, we can identify unique therapeutic opportunities that can overcome treatment barriers and make a real difference for patients.
Leveraging established science
By focusing on known medicinal chemistry, molecular structures and/or disease pathways, we can utilize existing pharmacology to reap substantial advantages in the drug development process. These can include:
Applying key scientific and technological expertise
In order to maximize product development opportunities, we tap into the full range of capabilities and expertise across the drug development continuum—from biology and medicinal chemistry innovation to clinical development, from engineering and formulation development to commercial-scale manufacturing.
Positioning for success
Because we design drugs specifically to address specific improvements in patient outcomes, our drug products are distinctive within their markets.
This page is intended for healthcare professionals only.
You are now leaving Alkermes.com.
